Haplotype-based, case–control study of the receptor (calcitonin) activity-modifying protein (RAMP) 1 gene in essential hypertension

• Published in: Journal of Human Hypertension Vol. 31; no. 5; pp. 361 - 365
• Main Authors: Nakayama, T, Nakazato, T, Naruse, H, Fu, Z, Wang, Z, Soma, M, Hoshino, T, Shimodaira, M, Aoi, N
• Format: Journal Article
• Language: English
• Published: London Springer Science and Business Media LLC 01.05.2017; Nature Publishing Group UK; Nature Publishing Group
• Subjects: 45/77; 631/208; 692/499; Adrenomedullin; Aged; Alleles; Biotechnology; Calcitonin; Case-Control Studies; Causes of; Cytokines; Drug therapy; Epidemiology; Essential Hypertension; Essential Hypertension - diagnosis; Essential Hypertension - epidemiology; Essential Hypertension - genetics; Female; Genetic aspects; Genetic markers; Haplotypes; HapMap Project; Health Administration; Health aspects; Humans; Hypertension; Inflammation; Japan; Japan - epidemiology; Male; Medicine; Medicine & Public Health; Middle Aged; original-article; Polymorphism, Single Nucleotide; Public Health; Receptor activity modifying proteins; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Protein 1 - genetics; Single nucleotide polymorphisms; Single-nucleotide polymorphism; Testing; Vasodilation; Japan
• DOI: 10.1038/jhh.2016.96
• ISSN: 0950-9240

The adrenomedullin receptor is a complex molecule that comprises the calcitonin-receptor-like receptor (CRLR) and the receptor-activity-modifying protein (RAMP). RAMP1 is a vasodilation factor, and RAMP1-deficient mice (RAMP1(−/−)) exhibit inflammatory responses with a significant transient increase in serum calcitonin-gene-related peptide levels and proinflammatory cytokines when compared with RAMP1(+/+) mice. The purpose of the present study was to investigate the relationships between essential hypertension (EH) and RAMP1 gene single-nucleotide polymorphisms (SNPs) or haplotypes in a Japanese population via a case–control study. Based on a database search of the National Center of Biotechnology Information website and the HapMap project, we chose six RAMP1 gene SNPs and performed an association study involving 263 patients with EH and 267 age-matched normotensive (NT) subjects. There was no significant difference between the EH and NT groups with regard to overall distribution of genotypes or SNP alleles. However, the haplotype-based case–control analysis revealed that there was a significant difference between the EH and NT groups with regard to overall distribution of the allele combinations at three SNPs—rs3754701–rs3769048–rs10199956—( P =0.002). The T-A-T haplotype was significantly more common in the EH group (10.3%) than in the NT control group (6.1%) ( P =0.047). These results suggested that this T-A-T RAMP1 gene haplotype might have utility as a genetic marker for EH and that the RAMP1 gene or a neighbouring gene may be associated with increased susceptibility to EH.